Development
Johnson & Johnson
JNJ
$167.33
$2.591.57%
NYSE
| 12/31/2023 | 10/01/2023 | 07/02/2023 | 04/02/2023 | 01/01/2023 | |
|---|---|---|---|---|---|
| Net Income | 9.13B | 8.60B | 13.05B | 12.72B | 17.94B |
| Total Depreciation and Amortization | 5.27B | 4.95B | 6.63B | 6.44B | 6.33B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.21B | 625.00M | 796.00M | 317.00M | 935.00M |
| Change in Net Operating Assets | 3.11B | -1.38B | -1.41B | 991.00M | -4.01B |
| Cash from Operations | 15.30B | 12.79B | 19.07B | 20.47B | 21.19B |
| Capital Expenditure | -4.05B | -3.57B | -4.53B | -4.27B | -4.01B |
| Sale of Property, Plant, and Equipment | 237.00M | 337.00M | 345.00M | 335.00M | 543.00M |
| Cash Acquisitions | -- | -17.13B | -17.13B | -17.40B | -17.65B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.15B | 15.51B | 14.75B | 15.91B | 8.75B |
| Cash from Investing | -1.66B | -4.86B | -6.56B | -5.42B | -12.37B |
| Total Debt Issued | 21.18B | 28.93B | 31.66B | 31.89B | 16.14B |
| Total Debt Repaid | -16.49B | -15.86B | -18.46B | -11.58B | -8.68B |
| Issuance of Common Stock | 187.00M | 422.00M | 509.00M | 1.01B | 1.33B |
| Repurchase of Common Stock | -4.13B | -5.24B | -7.40B | -8.01B | -6.04B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.90B | -8.99B | -11.96B | -11.84B | -11.68B |
| Other Financing Activities | 3.40B | 2.32B | 3.33B | 186.00M | 65.00M |
| Cash from Financing | -4.51B | 1.85B | -2.08B | 1.65B | -8.87B |
| Foreign Exchange rate Adjustments | 56.00M | 50.00M | -236.00M | -300.00M | -312.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.19B | 9.83B | 10.20B | 16.40B | -360.00M |